1. Home
  2. BEAM vs AAUC Comparison

BEAM vs AAUC Comparison

Compare BEAM & AAUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$28.45

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Allied Gold Corporation

AAUC

Allied Gold Corporation

HOLD

Current Price

$23.24

Market Cap

3.1B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
AAUC
Founded
2017
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
BEAM
AAUC
Price
$28.45
$23.24
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$50.75
N/A
AVG Volume (30 Days)
1.6M
778.6K
Earning Date
05-06-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
82.31
N/A
EPS
N/A
N/A
Revenue
$24,000.00
N/A
Revenue This Year
N/A
$94.92
Revenue Next Year
$33.77
$27.93
P/E Ratio
N/A
N/A
Revenue Growth
33.33
N/A
52 Week Low
$16.03
$13.61
52 Week High
$38.26
$32.20

Technical Indicators

Market Signals
Indicator
BEAM
AAUC
Relative Strength Index (RSI) 51.71 56.69
Support Level $28.03 $22.15
Resistance Level $28.96 $25.01
Average True Range (ATR) 1.28 0.94
MACD 0.45 0.37
Stochastic Oscillator 57.10 84.43

Price Performance

Historical Comparison
BEAM
AAUC

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About AAUC Allied Gold Corporation

Allied Gold Corp is a company focused on gold mining activities in Africa. Allied has three mines and several development and exploration projects in Africa, where it has operating experience. Operations are located in Cote d'Ivoire, Mali, and Ethiopia. The company expands and optimizes initiatives at existing operating mines, develops new mines, advances its exploration properties, and targets other consolidation opportunities, with a focus on Africa.

Share on Social Networks: